New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production Site provides the world’s largest HPL output with 20,000L annual capacity and a dual-source GMP strategy for secure, resilient supply from Aachen AACHEN, Germany — PL BioScience GmbH, a German life science company specializing in the production […]

Shimadzu Corporation and Kyoto University (Yoshida-honmachi, Sakyo-ku, Kyoto-shi) have signed a comprehensive collaborative agreement with the objective of creating new business activities and innovation to contribute to solving social problems, and training global high-level human resources. In 2022, both parties signed a three-year comprehensive collaborative agreement with the objective of creating new business activities by […]

Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina’s growing research and clinical oncology portfolio broadens access to critical biomarker testing SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its […]

LONDON, UK — Touchlight, a pioneer in cell-free DNA innovation, is proud to announce the commercial launch of their new technology for non-viral gene editing, mbDNA™ (megabulb DNA). Its novel circular single-stranded DNA (ssDNA) structure features a customisable stem region and a fully user-defined sequence free of phage or bacterial elements. mbDNA’s design supports 1-20kb gene insertions […]

Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience leadership to potentially unlock breakthrough therapeutics and biomarkers for neurodegenerative disease SEATTLE — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced […]

Strategic expansion places Aldevron at the heart of the Boston biotech corridor, fueling next-generation breakthroughs in genomic medicine FARGO, N.D. & WALTHAM, Mass. — Aldevron, a Danaher company, and a global leader in the production of DNA, RNA and protein in the genomic medicine space, today announced the planned opening of its new Innovation Center […]

Lausanne, Switzerland & Murcia, Spain — Saphetor, the creators of the industry-leading VarSome suite of NGS bioinformatics tools, announces a new partnership with LongSeq, a Spanish biotechnology company specialized in advanced long-read DNA sequencing. Through this collaboration, LongSeq becomes an official distributor of VarSome Clinical for long-read sequencing in Spain. LongSeq has been working with Oxford Nanopore Technologies for […]

Leaders in pioneering cancer diagnostics and NGS target enrichment technologies join forces to accelerate access to advanced molecular diagnostics for cancer FREMONT, Calif. and TAIZHOU, China — Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), and Genecast (Taizhou) Biotechnology Co., Ltd., a pioneering oncology diagnostics company, today announced a […]

Sonication Star is a Hands-Free, High Performance FFPE Nucleic Acid Extraction with truXTRAC FFPE SMART Solution WOBURN, MA and RENO, NV — Covaris, a PerkinElmer company and pioneer in sample preparation technologies, and Hamilton Company, a global leader in automation solutions, announce a strategic partnership to co-market the truXTRAC® FFPE SMART Solution, powered by the […]

NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced a strategic collaboration with the German Center for Neurodegenerative Diseases (DZNE) to deploy its ultra-sensitive NULISAseq™ CNS Disease Panel […]